Brandinium

Trademark search for:

THERAPASE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2007-10-17 — Application filed
  • 2007-10-22 — Application filed
  • 2008-01-28 — Assigned to examiner
  • 2008-01-29 — Final disposition recorded
  • 2008-01-29 — Final disposition recorded
  • 2008-01-29 — Final disposition recorded
  • 2008-07-14 — Teas/email correspondence entered
  • 2008-07-14 — Office action issued
  • 2008-07-14 — Correspondence received in law office
  • 2008-08-08 — Suspension letter written
  • 2008-08-08 — Letter of suspension e-mailed
  • 2008-08-08 — Notification of letter of suspension e-mailed
  • 2008-11-25 — Teas response to suspension inquiry received
  • 2008-11-25 — Teas/email correspondence entered
  • 2008-11-25 — Correspondence received in law office
  • 2008-12-12 — Approved for pub - principal register
  • 2008-12-22 — Assigned to lie
  • 2008-12-22 — Law office publication review completed
  • 2009-01-07 — Notice of publication
  • 2009-01-27 — Published for opposition
  • 2009-04-21 — Noa mailed - sou required from applicant
  • 2009-09-16 — Automatic update of assignment of ownership
  • 2009-09-17 — Attorney/dom.rep.revoked and/or appointed
  • 2009-09-17 — Teas revoke/app/change addr of atty/dom rep received
  • 2009-10-14 — Sou teas extension received
  • 2009-10-14 — Sou extension 1 filed
  • 2009-11-02 — Case assigned to intent to use paralegal
  • 2009-11-02 — Sou extension 1 granted
  • 2010-02-19 — Sou teas extension received
  • 2010-02-19 — Sou extension 2 filed
  • 2010-02-23 — Sou extension 2 granted
  • 2010-08-23 — Sou teas extension received
  • 2010-08-23 — Sou extension 3 filed
  • 2010-08-24 — Sou extension 3 granted
  • 2010-08-25 — Notice of approval of extension request e-mailed
  • 2010-10-29 — Teas delete 1(b) basis received
  • 2010-10-29 — Notice of allowance cancelled
  • 2010-11-10 — 1(b) basis deleted; proceed to registration
  • 2011-01-18 — Registered-principal register
  • 2011-01-24 — Attorney/dom.rep.revoked and/or appointed
  • 2011-01-24 — Teas revoke/app/change addr of atty/dom rep received
  • 2013-12-25 — Automatic update of assignment of ownership
  • 2016-01-18 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2016-08-10 — Automatic update of assignment of ownership
  • 2017-08-25 — Cancelled sec. 8 (6-yr)
  • 2017-08-25 — Final status recorded

Owner Information

BAYER INTELLECTUAL PROPERTY GMBH
MONHEIM AM RHEIN DE
BAYER PHARMA AKTIENGESELLSCHAFT
BERLIN DE
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
BERLIN DE
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
BERLIN DE
DIREVO BioTech AG
Köln DE
DIREVO BioTech AG
Köln DE

Correspondent

Jeffrey M. Gitchel Bayer Corporation
100 Bayer Road
Pittsburgh, PA 15205
UNITED STATES

Filing Details

Filing Date:
2007-10-17
Status Date:
2017-08-25
Category:
Pharmaceuticals
Filing Year:
2007

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.